Canadian Pacific Kansas City Limited Common Shares vs DexCom, Inc. — how do they compare? Canadian Pacific Kansas City Limited Common Shares trades at $83.86 (market cap $73.71B), while DexCom, Inc. trades at $84.38 (market cap $31.81B). The key difference: Canadian Pacific Kansas City Limited Common Shares is far larger — about 2.3× DexCom, Inc.'s market cap, and Canadian Pacific Kansas City Limited Common Shares pays a 0.91% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals.
| CP | DXCM | |
|---|---|---|
Market Cap | $73.71B | $31.81B |
Volume | 2,143,178 | 2,861,821 |
Sector | Industrials | Health |
52-Week High | $96.69 | $92.34 |
52-Week Low | $68.88 | $54.84 |
Enterprise Value | $91.14B | $31.26B |
Dividend Yield | 0.91% | — |
Typical Hold Time | — | 62 Days |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
DexCom (DXCM) trades at $84.41, showing modest daily gains of 1.22% amid a bearish technical outlook. The company demonstrates strong fundamental performance with consistent earnings beats, including Q2 2026 EPS of $0.70 exceeding expectations of $0.611. Revenue growth remains robust, climbing from $2.9B in 2022 to $4.7B in 2025, while net income margins improved to 17.93%. Recent news highlights expansion opportunities in Type 2 diabetes care and executive promotions.
Wall Street maintains a bullish stance with 81% buy ratings and a $95.07 consensus price target, representing 13% upside potential. Key risks include competitive pressures in CGM markets and reimbursement challenges. The company's strong cash flow generation and expanding market opportunity in diabetes technology support long-term growth prospects despite current technical weakness.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Canadian Pacific Kansas City operates a freight railway connecting Canada, the United States, and Mexico. The company was formed through the combination of Canadian Pacific and Kansas City Southern.
Read more on CP →Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →